Tarian Pharma
Developing a topical treatment to prevent skin toxicities in patients receiving cancer therapies
Highlights
- New on EvolcAdded 2026-11-11
About Tarian Pharma
Tarian Pharma is a clinical-stage pharmaceutical company developing TAR-0520 (Tarian Gel), a topical extended-release brimonidine tartrate formulation intended to prevent skin toxicities associated with cancer treatments. The investigational product is being evaluated in Phase 2 studies across oncology supportive-care indications.
The company serves cancer patients and the clinicians involved in their care. It is developing the product for potential use within oncology care pathways; the product has not been approved for commercial use.
Tarian Pharma was founded in 2020 and is headquartered in Grasse, France. It was founded by three dermatology drug-development experts.
Product: TAR-0520 (Tarian Gel), an investigational topical extended-release brimonidine tartrate formulation for preventing cancer-treatment-related skin toxicities.
Jobs at Tarian Pharma
Leadership
- Philippe ANDRES · CEOSource: company website
- Gareth WINCKLE · CTOSource: company website
More biotech & pharma companies
Tebu Bio
Life science research products and CRO services for biotechnology and life sciences researchersTech In Care
Biotechnology research connecting epigenetics, metabolomics and AI to explore biology, environment and healthNew on EvolcTedis
Pharmaceutical wholesale distributor linking laboratories with pharmacies and hospitals in France and export markets in Africa and AsiaSalary transparentTelomium
Develops ribonucleoprotein-based cancer immunotherapies for patients with cancerNew on EvolcTemisis
Develops preclinical small-molecule treatments for inflammatory diseases, including psoriasisNew on EvolcTerratis
Sterile-insect mosquito control services for French municipalities and other high-traffic public areasYoung companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.